Efficacy, Safety, and Tolerability of Desvenlafaxine 50 mg/d for the Treatment of Major Depressive Disorder:A Systematic Review of Clinical Trials

Lignende værker

• A double-blind, randomized, placebo-controlled study assessing the efficacy and tolerability of desvenlafaxine 10 and 50 mg/day in adult outpatients with major depressive disorder
  af: Liebowitz, Michael R, et al.
  Udgivet: (2013)
• Safety and Tolerability of Desvenlafaxine in Children and Adolescents with Major Depressive Disorder
  af: Findling, Robert L., et al.
  Udgivet: (2014)
• Efficacy of Desvenlafaxine 50 mg/d Versus Placebo in the Long-Term Treatment of Major Depressive Disorder: A Randomized, Double-Blind Trial
  af: Boyer, Patrice, et al.
  Udgivet: (2015)
• Desvenlafaxine and Weight Change in Major Depressive Disorder
  af: Tourian, Karen A., et al.
  Udgivet: (2010)
• Speed of Improvement in Symptoms of Depression With Desvenlafaxine 50 mg and 100 mg Compared With Placebo in Patients With Major Depressive Disorder
  af: Katzman, Martin A., et al.
  Udgivet: (2017)